Fecha de publicación: 29/09/2014 Fuente: WIPO "propolis" The present invention is directed to a novel use of prenylflavanone compounds isolated from Taiwanese green propolis for control of blood glucose and treatment or prevention of diabetes. For instance, the prenylflavanone compounds are selected from PPC, PPD, PPF, PPG, PPI, PPA, PPB, Pokinawan, (S,E)-2-(3,4-dihydroxy-2-(7-hydroxy-3,7-dimethyloct-2-en-1-yl)phenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methylbutyl)-3,4-dihydro-2H-1-benzopyran-4-one and (S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-((2E,6E)-11-hydroxy-3,7,11-trimethyldodeca-2, 6-dien-1-yl)-3,4-dihydro-2H-1-benzopyran-4-one.